Richard Anderson
Stock Analyst at Cantor Fitzgerald
(3.56)
# 948
Out of 5,182 analysts
208
Total ratings
58.33%
Success rate
2.7%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NHI National Health Investors | Reiterates: Overweight | $94 | $76.62 | +22.68% | 6 | Apr 22, 2026 | |
| SNDA Sonida Senior Living | Initiates: Overweight | $36 | $37.80 | -4.76% | 1 | Apr 13, 2026 | |
| JAN Janus Living | Initiates: Overweight | $27 | $25.26 | +6.89% | 1 | Apr 13, 2026 | |
| HPP Hudson Pacific Properties | Maintains: Overweight | $13 → $10 | $9.79 | +2.15% | 8 | Mar 2, 2026 | |
| HR Healthcare Realty Trust | Maintains: Overweight | $19 → $21 | $18.59 | +12.96% | 11 | Feb 17, 2026 | |
| CTRE CareTrust REIT | Maintains: Neutral | $37 → $42 | $39.71 | +5.77% | 5 | Feb 17, 2026 | |
| SBRA Sabra Health Care REIT | Maintains: Neutral | $20 → $21 | $20.51 | +2.39% | 7 | Feb 17, 2026 | |
| WELL Welltower | Maintains: Overweight | $204 → $230 | $214.23 | +7.36% | 8 | Feb 12, 2026 | |
| UDR UDR, Inc. | Maintains: Neutral | $37 → $42 | $36.21 | +15.99% | 6 | Feb 11, 2026 | |
| OHI Omega Healthcare Investors | Maintains: Overweight | $50 → $52 | $47.42 | +9.66% | 3 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $137 → $141 | $130.38 | +8.15% | 6 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $300 | $267.88 | +11.99% | 10 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $61 → $64 | $65.15 | -1.77% | 7 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $105 → $108 | $105.93 | +1.95% | 6 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $179 → $186 | $183.50 | +1.36% | 3 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $93 | $87.57 | +6.20% | 10 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $37 | $32.09 | +15.30% | 5 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $75 | $66.07 | +13.52% | 4 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $45 | $35.84 | +25.56% | 3 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $64 | $62.48 | +2.43% | 7 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $200 → $210 | $202.22 | +3.85% | 8 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $79 | $59.16 | +33.54% | 8 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $11.12 | +16.91% | 4 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $79 → $52 | $40.41 | +28.68% | 10 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $37 | $28.65 | +29.14% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $15 | $15.61 | -3.91% | 5 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $14 | $12.63 | +10.85% | 3 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $37 | $39.56 | -6.47% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $17 | $15.96 | +6.52% | 6 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $108 | $103.76 | +4.09% | 2 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $12 | $11.29 | +6.29% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $12 | $14.11 | -14.95% | 3 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $64 | $63.55 | +0.71% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $20.61 | +1.89% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $38 | $38.43 | -1.12% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $19 | $20.94 | -9.26% | 3 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $51 | $48.02 | +6.21% | 3 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $31.35 | +11.64% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $16.05 | +24.61% | 6 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $62 | $68.38 | -9.33% | 2 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $20.03 | +4.84% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $14 | $13.39 | +4.56% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.26 | - | 5 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.08 | - | 2 | Jul 10, 2017 |
National Health Investors
Apr 22, 2026
Reiterates: Overweight
Price Target: $94
Current: $76.62
Upside: +22.68%
Sonida Senior Living
Apr 13, 2026
Initiates: Overweight
Price Target: $36
Current: $37.80
Upside: -4.76%
Janus Living
Apr 13, 2026
Initiates: Overweight
Price Target: $27
Current: $25.26
Upside: +6.89%
Hudson Pacific Properties
Mar 2, 2026
Maintains: Overweight
Price Target: $13 → $10
Current: $9.79
Upside: +2.15%
Healthcare Realty Trust
Feb 17, 2026
Maintains: Overweight
Price Target: $19 → $21
Current: $18.59
Upside: +12.96%
CareTrust REIT
Feb 17, 2026
Maintains: Neutral
Price Target: $37 → $42
Current: $39.71
Upside: +5.77%
Sabra Health Care REIT
Feb 17, 2026
Maintains: Neutral
Price Target: $20 → $21
Current: $20.51
Upside: +2.39%
Welltower
Feb 12, 2026
Maintains: Overweight
Price Target: $204 → $230
Current: $214.23
Upside: +7.36%
UDR, Inc.
Feb 11, 2026
Maintains: Neutral
Price Target: $37 → $42
Current: $36.21
Upside: +15.99%
Omega Healthcare Investors
Feb 10, 2026
Maintains: Overweight
Price Target: $50 → $52
Current: $47.42
Upside: +9.66%
Feb 9, 2026
Maintains: Neutral
Price Target: $137 → $141
Current: $130.38
Upside: +8.15%
Feb 9, 2026
Reiterates: Overweight
Price Target: $300
Current: $267.88
Upside: +11.99%
Feb 9, 2026
Maintains: Neutral
Price Target: $61 → $64
Current: $65.15
Upside: -1.77%
Feb 9, 2026
Maintains: Neutral
Price Target: $105 → $108
Current: $105.93
Upside: +1.95%
Feb 9, 2026
Maintains: Neutral
Price Target: $179 → $186
Current: $183.50
Upside: +1.36%
Feb 9, 2026
Reiterates: Overweight
Price Target: $93
Current: $87.57
Upside: +6.20%
Feb 9, 2026
Maintains: Overweight
Price Target: $33 → $37
Current: $32.09
Upside: +15.30%
Feb 6, 2026
Maintains: Overweight
Price Target: $67 → $75
Current: $66.07
Upside: +13.52%
Feb 6, 2026
Maintains: Overweight
Price Target: $50 → $45
Current: $35.84
Upside: +25.56%
Feb 6, 2026
Maintains: Neutral
Price Target: $58 → $64
Current: $62.48
Upside: +2.43%
Feb 6, 2026
Maintains: Overweight
Price Target: $200 → $210
Current: $202.22
Upside: +3.85%
Jan 29, 2026
Reiterates: Overweight
Price Target: $79
Current: $59.16
Upside: +33.54%
Nov 6, 2025
Maintains: Neutral
Price Target: $16 → $13
Current: $11.12
Upside: +16.91%
Oct 30, 2025
Maintains: Neutral
Price Target: $79 → $52
Current: $40.41
Upside: +28.68%
Oct 1, 2025
Initiates: Overweight
Price Target: $37
Current: $28.65
Upside: +29.14%
Oct 1, 2025
Initiates: Neutral
Price Target: $15
Current: $15.61
Upside: -3.91%
Oct 1, 2025
Initiates: Overweight
Price Target: $14
Current: $12.63
Upside: +10.85%
Oct 1, 2025
Initiates: Neutral
Price Target: $37
Current: $39.56
Upside: -6.47%
Oct 1, 2025
Initiates: Neutral
Price Target: $17
Current: $15.96
Upside: +6.52%
Oct 1, 2025
Initiates: Overweight
Price Target: $108
Current: $103.76
Upside: +4.09%
Oct 1, 2025
Initiates: Neutral
Price Target: $12
Current: $11.29
Upside: +6.29%
Oct 1, 2025
Initiates: Neutral
Price Target: $12
Current: $14.11
Upside: -14.95%
Oct 1, 2025
Initiates: Neutral
Price Target: $64
Current: $63.55
Upside: +0.71%
Oct 1, 2025
Initiates: Overweight
Price Target: $21
Current: $20.61
Upside: +1.89%
Oct 1, 2025
Initiates: Neutral
Price Target: $38
Current: $38.43
Upside: -1.12%
Oct 1, 2025
Initiates: Neutral
Price Target: $19
Current: $20.94
Upside: -9.26%
Oct 1, 2025
Initiates: Neutral
Price Target: $51
Current: $48.02
Upside: +6.21%
Oct 1, 2025
Initiates: Overweight
Price Target: $35
Current: $31.35
Upside: +11.64%
Oct 1, 2025
Initiates: Neutral
Price Target: $20
Current: $16.05
Upside: +24.61%
Oct 1, 2025
Initiates: Neutral
Price Target: $62
Current: $68.38
Upside: -9.33%
Oct 1, 2025
Initiates: Overweight
Price Target: $21
Current: $20.03
Upside: +4.84%
Oct 1, 2025
Initiates: Overweight
Price Target: $14
Current: $13.39
Upside: +4.56%
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $4.26
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $3.08
Upside: -